Elmind Capital, LP
34 holdingsFiling period: 2026-03-31Current AUM: $359.7Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | 1.17M | $45.1M | $45.6M | 12.67% | -- | 2026-03-31 |
| 2 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.85M | $43.3M | $35.3M | 9.82% | -- | 2026-03-31 |
| 3 | CLDX | CELLDEX THERAPEUTICS INC NEW | 865.0K | $27.4M | $32.9M | 9.15% | -- | 2026-03-31 |
| 4 | CTMX | CYTOMX THERAPEUTICS INC. | 4.55M | $21.4M | $14.1M | 3.92% | +3.85M | 2026-03-31 |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | 1.02M | $20.6M | $20.6M | 5.72% | +220.0K | 2026-03-31 |
| 6 | CGON | CG ONCOLOGY INC | 291.8K | $19.7M | $20.8M | 5.77% | -200,700 | 2026-03-31 |
| 7 | VERA | VERA THERAPEUTICS INC | 482.5K | $19.4M | $15.5M | 4.31% | -- | 2026-03-31 |
| 8 | PCVX | VAXCYTE INC | 316.5K | $18.4M | $17.1M | 4.76% | +25.0K | 2026-03-31 |
| 9 | — | PHARVARIS N V | 475.8K | $13.4M | $13.4M | 3.74% | -- | 2026-03-31 |
| 10 | TYRA | TYRA BIOSCIENCES INC | 350.0K | $13.4M | $11.2M | 3.10% | -- | 2026-03-31 |
| 11 | BEAM | BEAM THERAPEUTICS INC | 476.3K | $11.4M | $12.2M | 3.38% | -- | 2026-03-31 |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | 534.9K | $10.5M | $10.1M | 2.81% | -323,700 | 2026-03-31 |
| 13 | BCRX | BIOCRYST PHARMACEUTICALS INC | 1.00M | $9.5M | $9.0M | 2.50% | -1,150,000 | 2026-03-31 |
| 14 | UTHR | UNITED THERAPEUTICS CORP DEL | 15.0K | $8.9M | $7.8M | 2.16% | +4.0K | 2026-03-31 |
| 15 | CGEM | CULLINAN THERAPEUTICS INC | 530.0K | $7.5M | $8.7M | 2.43% | +220.0K | 2026-03-31 |
| 16 | NRIX | NURIX THERAPEUTICS INC | 460.0K | $7.1M | $10.7M | 2.97% | -- | 2026-03-31 |
| 17 | MBX | MBX BIOSCIENCES INC | 211.0K | $6.3M | $13.9M | 3.87% | -- | 2026-03-31 |
| 18 | KRYS | KRYSTAL BIOTECH INC | 22.0K | $5.7M | $7.5M | 2.09% | -- | 2026-03-31 |
| 19 | DBVT | DBV TECHNOLOGIES S A | 265.0K | $5.5M | $3.6M | 0.99% | -- | 2026-03-31 |
| 20 | RLAY | RELAY THERAPEUTICS INC | 536.9K | $5.3M | $10.1M | 2.81% | -- | 2026-03-31 |
| 21 | TVTX | TRAVERE THERAPEUTICS INC | 177.6K | $5.3M | $9.9M | 2.76% | +67.6K | 2026-03-31 |
| 22 | PTGX | PROTAGONIST THERAPEUTICS INC | 38.0K | $4.0M | $5.2M | 1.44% | -- | 2026-03-31 |
| 23 | — | UROGEN PHARMA LTD | 220.0K | $4.0M | $4.0M | 1.10% | +120.0K | 2026-03-31 |
| 24 | ALMS | ALUMIS INC | 130.0K | $2.9M | $3.7M | 1.02% | -- | 2026-03-31 |
| 25 | BMRN | BIOMARIN PHARMACEUTICAL INC | 47.0K | $2.7M | $2.8M | 0.78% | -35,000 | 2026-03-31 |
← Scroll →
Page 1 of 2